voice search
Docetaxel Injection 20mg1ml
Share

Docetaxel Injection 20mg1ml

Price:

Get Latest Price

In Stock

In Stock

Product Overview

Key Features

We are involved in exporting, trading and supplying excellent quality Docetaxel Injection 20mg1ml to our most valued clients. Our offered Docetaxel Injection 20mg1ml is widely appreciated by our clients which are situated all round the nation. We offer Docetaxel Injection 20mg1ml at most affordable prices.
Available in : 20mg1ml & 80mg4mL & 160mg8mL.

Company Details

Sundent Healthcare Co., Ltd., Established in 1997 at Shanghai in Shanghai, is a leading Exporter,Manufacturer,Supplier of Pharmaceutical Ointments & Creams in China. Sundent Healthcare Co., Ltd. is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading Docetaxel Injection 20mg1ml, Sundent Healthcare Co., Ltd. has made a reputed name for itself in the market with high-quality Artemether Injection, Calcium Gluconate Injection, Docetaxel Injection 20mg1ml, etc.
Focusing on a customer-centric approach, Sundent Healthcare Co., Ltd. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Ointments & Creams in bulk from Sundent Healthcare Co., Ltd. at Trade India quality-assured products.

Business Type

Exporter, Manufacturer, Supplier

Establishment

1997

Working Days

Monday To Sunday

Related Products

Explore Related Categories

More Product From This seller

Seller Details

Shanghai, Shanghai

Ms. Tracy Zhang

Address

No. 66, Vanke Hongqiao Cloud, No. 1333, Xinlong Road, Minhang District, Shanghai, Shanghai, 201101, China

Report incorrect details

Compare With Similar Products

Formulations Type

Treatments & Functions

Docetaxel Injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Non-Small Cell Lung Cancer

Docetaxel Injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Non-Small Cell Lung Cancer

Gender/Age Group

Storage Instructions

Molecular Formula

C43H53NO14a c 3H2O

C43H53NO14a c 3H2O

Formulations Form

Application

Certifications

WHO GMP APPROVED PHARMACY & PPOISONS BOARD, KENYA Department of Drug Administration (DDA), Ministry of Health and Population (MOHP)/Government of Nepal (GoN) NATIONAL MEDICINES AND POISONS BOARD, REPUBLIC OF SUDAN MINISTERY OF PUBLIC HEALTH & POPULATION, REPUBLIC OF YEMEN

WHO GMP APPROVED PHARMACY & PPOISONS BOARD, KENYA Department of Drug Administration (DDA), Ministry of Health and Population (MOHP)/Government of Nepal (GoN) NATIONAL MEDICINES AND POISONS BOARD, REPUBLIC OF SUDAN MINISTERY OF PUBLIC HEALTH & POPULATION, REPUBLIC OF YEMEN

Main Export Market(s)

South America

South America

Payment Terms

Letter of Credit at Sight (Sight L/C)

Letter of Credit at Sight (Sight L/C)

People Also Viewed